Niittyvuopio Riitta, Juvonen Eeva, Kaaja Risto, Oksanen Kalevi, Hallman Heikki, Timonen Timo, Ruutu Tapani
Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Eur J Haematol. 2004 Dec;73(6):431-6. doi: 10.1111/j.1600-0609.2004.00324.x.
In this study, the course of 40 pregnancies in 16 women with essential thrombocythaemia (ET) was analysed retrospectively. Of the pregnancies, 45% were complicated, 55% uncomplicated, and 62% resulted in live birth. The most common complication was spontaneous abortion during the first trimester seen in 33% of all pregnancies and comprising 72% of all complications. Two intrauterine foetal deaths occurred at weeks 22 and 28. Three pregnancies were complicated by eclampsia or pre-eclampsia. Nine of 16 women with 29 pregnancies had at least one complicated pregnancy. In seven of 16 women, all 11 pregnancies were uneventful. The non-pregnancy-related symptoms of ET or the platelet count before conception or during pregnancy did not correlate with the risk of pregnancy complications. Treatment with low-dose acetylsalicylic acid (ASA) alone during pregnancy or platelet-lowering drugs before or during pregnancy reduced the risk of complications.
在本研究中,对16例原发性血小板增多症(ET)女性的40次妊娠过程进行了回顾性分析。其中,45%的妊娠有并发症,55%无并发症,62%的妊娠分娩活婴。最常见的并发症是孕早期自然流产,占所有妊娠的33%,占所有并发症的72%。妊娠22周和28周时发生了2例宫内胎儿死亡。3例妊娠并发子痫或先兆子痫。16例有29次妊娠的女性中,9例至少有1次妊娠合并症。16例女性中有7例,其11次妊娠均无异常。ET的非妊娠相关症状或受孕前或孕期的血小板计数与妊娠并发症风险无关。孕期单独使用低剂量乙酰水杨酸(ASA)或孕前或孕期使用降血小板药物可降低并发症风险。